Elicio Therapeutics, Inc. (ELTX)

NASDAQ: ELTX · IEX Real-Time Price · USD

9.10

-0.15 (-1.62%)

At close: Apr 25, 2024, 4:00 PM

9.30

+0.20 (2.20%)

After-hours: Apr 25, 2024, 7:39 PM EDT

Elicio Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	93	70	24	87	-	-
Market Cap Growth	-	186.88%	-71.87%	-	-	-
Enterprise Value	86	63	24	3	22	5
PE Ratio	-1.99	-1.99	-0.87	-1.59	-	-
PS Ratio	-	-	-	3.07	-	-
PB Ratio	8.18	6.17	-0.24	1.07	-	-
P/FCF Ratio	-2.14	-2.14	-1.07	-1.64	-	-
P/OCF Ratio	-2.14	-2.14	-1.10	-1.65	-	-
EV/Sales Ratio	-	-	-	0.10	7.61	3.50
EV/EBITDA Ratio	-1.92	-1.92	-1.02	-0.05	-0.31	-0.13
EV/EBIT Ratio	-1.86	-1.86	-0.98	-0.05	-0.31	-0.13
EV/FCF Ratio	-1.94	-1.94	-1.06	-0.05	-0.96	-0.21
Debt / Equity Ratio	0.61	0.61	-0.07	0.06	-0.62	-0.58
Debt / EBITDA Ratio	-0.21	-0.21	-0.32	-0.09	-0.80	-0.27
Debt / FCF Ratio	-0.21	-0.21	-0.33	-0.09	-2.47	-0.43
Quick Ratio	1.39	1.39	1.14	7.93	0.32	0.23
Current Ratio	1.67	1.67	1.56	8.08	0.39	0.23
Asset Turnover	0	0	0	0.24	0.10	0.08
Interest Coverage	-32.23	-32.23	-6.84	-28.55	-8.06	-
Return on Equity (ROE)	-160.20%	-160.20%	-150.40%	-69.20%	146.90%	-25020.30%
Return on Assets (ROA)	-102.40%	-102.40%	-47.80%	-46.30%	-270.50%	-211.10%
Return on Capital (ROIC)	-195.43%	-195.43%	25.07%	-45.62%	162.92%	494.25%
Earnings Yield	-37.84%	-50.20%	-115.42%	-62.82%	-	-
FCF Yield	-35.19%	-46.67%	-93.42%	-61.04%	-	-
Buyback Yield / Dilution	-1500.08%	-1500.08%	88.81%	-91.33%	-2.26%	-49.03%
Total Shareholder Return	-1500.08%	-1500.08%	88.81%	-91.33%	-2.26%	-49.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).